外伤性增生性玻璃体视网膜病变的防治研究进展
Research progress in the prevention and treatment of traumatic proliferative vitreoretinopathy
王晓琳 1朱婷 2徐达华 3陈梅4
作者信息
- 1. 中南大学爱尔眼科研究院,长沙 410009
- 2. 汕头国际眼科中心,汕头 515041
- 3. 湖北医药学院附属太和医院眼科,十堰 442012
- 4. 重庆爱尔眼科医院,重庆 400020
- 折叠
摘要
外伤性增生性玻璃体视网膜病变(TPVR)是开放性眼外伤的常见并发症,是导致外伤患者术后出现复发性视网膜脱离等视力预后不佳的主要原因之一.随着手术显微技术的不断发展和日趋完善的手术操作方式,早期手术可以减少TPVR的发生,且TPVR手术预后较前也有很大提升.但除手术治疗外,尚无其他公认的治疗TPVR的有效手段.基于此,对于TPVR的防治研究开展较多,许多药物及缓释给药在TPVR的治疗中取得了一定的疗效.本文从手术、药物及缓释治疗三方面对TPVR的防治进行总结,以期为开放性眼外伤患者的治疗提供新思路.
Abstract
Traumatic proliferative vitreoretinopathy(TPVR)is a common complication of open globe injury and is a major cause of poor visual prognosis in traumatic patients,such as recurrent retinal detachment after surgery.With the continuous development of surgical microscopic techniques and increasingly improved surgical practices,early surgery can reduce the occurrence for TPVR,and the prognosis for TPVR after surgery has greatly improved.However,there is no recognized effective treatment for TPVR other than surgical treatment.Based on this,lots of researches on the treatment for TPVR have been carried out,and many drugs and sustained-release administration have achieved certain efficacy in the treatment for TPVR.In this review,we summarize the prevention and treatment of TPVR from three aspects:surgery,drugs and sustained-release administration,in order to provide new ideas for the treatment of patients with open globe injury.
关键词
玻璃体视网膜病变,增生性,外伤性/手术/药物,缓释Key words
Vitreoretinopathy,proliferative,traumatic/Surgery/Drug,sustained-release引用本文复制引用
出版年
2024
NETL
NSTL
万方数据